VALIDATION IMAGES
IF(ICC) staining with EIF2AK4 (6G6) Monoclonal Antibody (bsm-54039R) at 1:100 in A549 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with EIF2AK4 (6G6) Monoclonal Antibody (bsm-54039R) at 1:100 in Hela cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with EIF2AK4 (6G6) Monoclonal Antibody (bsm-54039R) at 1:100 in MecF-7 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Paraformaldehyde-fixed and paraffin-embedded Human Tonsil tissue incubated with EIF2AK4 (6G6) Monoclonal Antibody (bsm-54039R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Breast Cancer tissue incubated with EIF2AK4 (6G6) Monoclonal Antibody (bsm-54039R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Placenta tissue incubated with EIF2AK4 (6G6) Monoclonal Antibody (bsm-54039R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Flow cytometric analysis of MCF-7 cells with EIF2AK4 (6G6) Monoclonal Antibody (bsm-54039R) at 1:100 dilution (red) compared with an unlabeled control (cells without incubation with primary antibody; black).